| Literature DB >> 20152514 |
Alex Shteynshlyuger1, Gerald L Andriole.
Abstract
The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective. Copyright (c) 2010 Elsevier Inc. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20152514 DOI： 10.1016/j.ucl.2009.11.004
Source DB: PubMed Journal: Urol Clin North Am ISSN： 0094-0143 Impact factor: 2.241